| TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma |
Globe Newswire |
08/19 |
14:00 |
| Mantle Cell Lymphoma Treatment Market is Projected to Reach US$ 5.77 Billion by 2034, with a 8.6% CAGR | Fact.MR Report |
Globe Newswire |
08/15 |
10:30 |
| Jet.AI Reports Second Quarter 2024 Financial Results |
Globe Newswire |
08/14 |
21:35 |
| Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates |
Globe Newswire |
08/14 |
20:30 |
| Enthusiast Gaming Reports Q2 2024 Results |
Globe Newswire |
08/14 |
20:10 |
| Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights |
Globe Newswire |
08/14 |
01:03 |
| Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights |
Globe Newswire |
08/13 |
20:01 |
| Sportradar Reports Second Quarter 2024 Financial and Operating Results |
Globe Newswire |
08/13 |
11:00 |
| Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update |
Globe Newswire |
08/13 |
10:40 |
| Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma |
Globe Newswire |
08/12 |
11:00 |
| ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
08/08 |
20:05 |
| Global Stem Cell Market to Cross ~USD 29 Billion Mark by 2030 | DelveInsight |
Globe Newswire |
08/08 |
17:00 |
| TuneIn Expands EV Integrations Through New Partnership with Sony Honda Mobility |
Globe Newswire |
08/08 |
15:38 |
| Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates |
Globe Newswire |
08/08 |
11:00 |
| Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
08/06 |
20:05 |
| Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results |
Globe Newswire |
08/06 |
20:01 |
| Sportradar to Participate in Canaccord Genuity 44th Annual Growth Conference |
Globe Newswire |
08/06 |
12:00 |
| ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update |
Globe Newswire |
08/06 |
11:30 |
| Game-Changing BCL-2 Inhibitors Set to Revolutionize Cancer Treatment Market | DelveInsight |
Globe Newswire |
08/05 |
17:00 |
| VSiN, The Sports Betting Network, Names Steve Cohen Executive Vice President of Talent and Programming |
Globe Newswire |
08/05 |
14:00 |
| DraftKings Reports Second Quarter Revenue Growth of 26% to $1,104 Million; Announces $1.0 Billion Inaugural Share Repurchase Authorization |
Globe Newswire |
08/02 |
11:00 |
| DraftKings Reports Second Quarter Revenue Growth of 26% to $1,104 Million; Announces $1.0 Billion Inaugural Share Repurchase Authorization |
Globe Newswire |
08/01 |
20:15 |
| Galapagos reports half-year 2024 financial results and provides second quarter business update |
Globe Newswire |
08/01 |
20:01 |
| Jet.AI Unveils Advanced AI Technology DynoFlight Platform |
Globe Newswire |
08/01 |
14:00 |
| C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights |
Globe Newswire |
08/01 |
11:00 |
